Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

519 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Histologic and Molecular Type Changes in Endometrial Cancer Recurrences in Comparison With Their Corresponding Primary Tumors.
Moreno-Moreno E, Caniego-Casas T, Carretero-Barrio I, Cortés A, Muriel A, Domínguez-Rullán JA, Martín-Gromaz C, Moreno-Bueno G, Matías-Guiu X, Palacios J, Pérez-Mies B. Moreno-Moreno E, et al. Among authors: matias guiu x. Am J Surg Pathol. 2024 Sep 13;48(12):1580-7. doi: 10.1097/PAS.0000000000002308. Online ahead of print. Am J Surg Pathol. 2024. PMID: 39269025 Free PMC article.
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer: towards the clinical application.
Casas-Arozamena C, Vilar A, Cueva J, Arias E, Sampayo V, Diaz E, Oltra SS, Moiola CP, Cabrera S, Cortegoso A, Curiel T, Abalo A, Pamies Serrano M, Domingo S, Padilla-Iserte P, Arnaez de la Cruz M, Hernández A, García-Pineda V, Ruiz-Bañobre J, López R, Matias-Guiu X, Colás E, Gil-Moreno A, Abal M, Moreno-Bueno G, Muinelo-Romay L. Casas-Arozamena C, et al. Among authors: matias guiu x. J Exp Clin Cancer Res. 2024 Sep 20;43(1):264. doi: 10.1186/s13046-024-03158-w. J Exp Clin Cancer Res. 2024. PMID: 39304963 Free PMC article.
FIGO 2023 staging for endometrial cancer, when, if it is not now?
Matias-Guiu X, Lax S, Raspollini MR, Palacios J, Zheng W, Liu C, de Brot L, Lordello L, Hardisson D, Gaffney D, Mutch D, Scambia G, Creutzberg CL, Fotopoulou C, Berek JS, Concin N. Matias-Guiu X, et al. Eur J Cancer. 2024 Dec;213:115115. doi: 10.1016/j.ejca.2024.115115. Epub 2024 Nov 5. Eur J Cancer. 2024. PMID: 39520836 Review.
Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.
Vrede SW, Van Weelden WJ, Bulten J, Gilks CB, Teerenstra S, Huvila J, Matias-Guiu X, Gil-Moreno A, Asberger J, Sweegers S, van der Putten LJM, Küsters-Vandevelde HVN, Reijnen C, Colas E, Hausnerová J, Weinberger V, Snijders MPLM, Vinklerova P, Ravaggi A, Odicino F, Bignotti E, McAlpine JN, Kruitwagen R, Pijnenborg JMA. Vrede SW, et al. Among authors: matias guiu x. Gynecol Oncol. 2024 Nov 7;192:15-23. doi: 10.1016/j.ygyno.2024.10.028. Online ahead of print. Gynecol Oncol. 2024. PMID: 39515079 Free article.
Biomarker characterization in endometrial cancer in Europe: first survey data analysis from 69 pathological academic and hospital labs.
Santoro A, Bragantini E, Castiglione F, Ganesan R, Matias-Guiu X, Frattini M, Gallotta V, Garcia P, Pattni Y, Tsiampali-Laprell J, Bisaro B, Barbareschi M, Zannoni GF; Collaborators (IT ESP UK, CH). Santoro A, et al. Pathologica. 2024 Feb;116(1):32-45. doi: 10.32074/1591-951X-926. Pathologica. 2024. PMID: 38482673 Free PMC article.
Total Effective Xenoestrogen Burden in Serum Samples and Risk of Endometrial Cancer in the Spanish Screenwide Case-Control Study.
Costas L, Frias-Gomez J, Peinado FM, Molina-Molina JM, Peremiquel-Trillas P, Paytubi S, Crous-Bou M, de Francisco J, Caño V, Benavente Y, Pelegrina B, Martínez JM, Pineda M, Brunet J, Matias-Guiu X, de Sanjosé S, Ponce J, Olea N, Alemany L, Fernández MF. Costas L, et al. Environ Health Perspect. 2024 Feb;132(2):27012. doi: 10.1289/EHP13202. Epub 2024 Feb 28. Environ Health Perspect. 2024. PMID: 38415615 Free PMC article.
Homologous recombination deficiency in ovarian cancer: Global expert consensus on testing and a comparison of companion diagnostics.
Quesada S, Penault-Llorca F, Matias-Guiu X, Banerjee S, Barberis M, Coleman RL, Colombo N, DeFazio A, McNeish IA, Nogueira-Rodrigues A, Oaknin A, Pignata S, Pujade-Lauraine É, Rouleau É, Ryška A, Van Der Merwe N, Van Gorp T, Vergote I, Weichert W, Wu X, Ray-Coquard I, Pujol P; expert consensus group. Quesada S, et al. Among authors: matias guiu x. Eur J Cancer. 2024 Dec 9;215:115169. doi: 10.1016/j.ejca.2024.115169. Online ahead of print. Eur J Cancer. 2024. PMID: 39693891
Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Creutzberg CL, Kim JW, Eminowicz G, Allanson E, Eberst L, Kim SI, Nout RA, Park JY, Lorusso D, Mileshkin L, Ottevanger PB, Brand A, Mezzanzanica D, Oza A, Gebski V, Pothuri B, Batley T, Gordon C, Mitra T, White H, Howitt B, Matias-Guiu X, Ray-Coquard I, Gaffney D, Small W Jr, Miller A, Concin N, Powell MA, Stuart G, Bookman MA; participants of the 2023 Gynecologic Cancer InterGroup Endometrial Cancer Consensus Conference on Clinical Research. Creutzberg CL, et al. Among authors: matias guiu x. Lancet Oncol. 2024 Sep;25(9):e420-e431. doi: 10.1016/S1470-2045(24)00192-X. Lancet Oncol. 2024. PMID: 39214113
519 results